We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+2.28%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$38.1B
AUM Growth
Cap. Flow
+$38.4B
Cap. Flow %
100.8%
Top 10 Hldgs %
11.4%
Holding
2,756
New
2,750
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$671M
2
MCD icon
McDonald's
MCD
+$636M
3
TSM icon
TSMC
TSM
+$515M
4
NVO
Novo Nordisk
NVO
+$465M
5
CL icon
Colgate-Palmolive
CL
+$458M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 14.45%
2 Healthcare 11.94%
3 Consumer Discretionary 11.58%
4 Consumer Staples 10.68%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENTR
2026
DELISTED
ENTROPIC COMMUNICATIONS INC COM STK (DE)
ENTR
$810K ﹤0.01%
+189,800
New +$796K
KNGT
2027
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
$810K ﹤0.01%
+48,150
New +$810K
NJ
2028
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
$806K ﹤0.01%
+92,000
New +$750K
ACW
2029
DELISTED
Accuride Corp
ACW
$805K ﹤0.01%
+159,160
New +$805K
PLAB icon
2030
Photronics
PLAB
$1.72B
$804K ﹤0.01%
+99,800
New +$747K
POWR
2031
DELISTED
POWERSECURE INTL INC COM STK (DE)
POWR
$804K ﹤0.01%
+53,500
New +$735K
SPAN
2032
DELISTED
Span-America Medical Systems I
SPAN
$804K ﹤0.01%
+39,400
New +$769K
PSHG icon
2033
Performance Shipping
PSHG
$22.5M
0
OTTR icon
2034
Otter Tail
OTTR
$3.93B
$801K ﹤0.01%
+28,210
New +$831K
DL
2035
DELISTED
China Distance Education Holdings Limited
DL
$800K ﹤0.01%
+112,700
New +$649K
PIPR icon
2036
Piper Sandler
PIPR
$5.24B
$797K ﹤0.01%
+100,800
New +$848K
ONE
2037
DELISTED
HIGHER ONE HOLDINGS, INC COM STK
ONE
$797K ﹤0.01%
+68,431
New +$700K
BGC
2038
DELISTED
General Cable Corporation
BGC
$793K ﹤0.01%
+25,800
New +$864K
LBAI
2039
DELISTED
Lakeland Bancorp Inc
LBAI
$790K ﹤0.01%
+79,507
New +$741K
CRRC
2040
DELISTED
COURIER CORP
CRRC
$788K ﹤0.01%
+55,200
New +$772K
GBL
2041
DELISTED
GAMCO Investors, Inc.
GBL
$787K ﹤0.01%
+26,369
New +$741K
BNCL
2042
DELISTED
Beneficial Bancorp, Inc.
BNCL
$787K ﹤0.01%
+102,996
New +$845K
DRL
2043
DELISTED
DORAL FINANCIAL CORPORATION (NEW)
DRL
$786K ﹤0.01%
+47,334
New +$847K
ULTR
2044
DELISTED
ULTRAPETROL (BAHAMAS) LTD COM STK
ULTR
$785K ﹤0.01%
+275,300
New +$740K
BREW
2045
DELISTED
Craft Brew Alliance, Inc.
BREW
$784K ﹤0.01%
+95,200
New +$727K
ARDNA
2046
DELISTED
ARDEN GROUP INC CL-A
ARDNA
$784K ﹤0.01%
+7,100
New +$784K
HRL icon
2047
Hormel Foods
HRL
$14.1B
$779K ﹤0.01%
+40,400
New +$821K
CASC
2048
DELISTED
Cascadian Therapeutics, Inc.
CASC
$779K ﹤0.01%
+82,683
New +$1.06M
TVTY
2049
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$778K ﹤0.01%
+44,789
New +$617K
IESC icon
2050
IES Holdings
IESC
$10.8B
$775K ﹤0.01%
+174,600
New +$961K

Similar funds

Renaissance Technologies's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Renaissance Technologies, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.

Its largest position is Eli Lilly: 12,326,205 shares worth $605M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.

  • Renaissance Technologies's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
  • Renaissance Technologies disclosed 2,756 positions in Q2 2013, its first 13F filing on record.

Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.